YKYasushi Kitaoka

Yasushi Kitaoka

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yasushi Kitaoka has a total of 85 co-authors. Here are the top co-authors by number of shared publications:

  • Kana Sase

    Department of Ophthalmology, St. Marianna University School of Medicine, Kawasaki, Kanagawa Japan

    11 shared publications
  • Yasunari Munemasa

    Department of Ophthalmology, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan

    9 shared publications
  • Chihiro Tsukahara

    Department of Ophthalmology, St. Marianna University School of Medicine, Kawasaki, Kanagawa Japan

    8 shared publications
  • Hitoshi Takagi

    Department of Ophthalmology, St. Marianna University School of Medicine, Kanagawa, Japan

    8 shared publications
  • Satoki Ueno

    8 shared publications
  • Naoki Fujita

    Department of Ophthalmology, St. Marianna University School of Medicine, Kawasaki, Kanagawa Japan

    6 shared publications

Latest Publications

  • Open Access

    Three-Year Fellow-Eye Comparison of Phacoemulsification Combined with iStent Inject W and Microhook Ab Interno Trabeculotomy in Primary Open-Angle Glaucoma

    by Akiko (Nishizawa) Endo, Naoto Tokuda, Ayaka Tsukamoto, Yasuhiro Toyoda, Yusuke Yamada, Kana Sase, Yasushi Kitaoka

    Background/Objectives: This study aimed to compare the three-year efficacy and safety of phacoemulsification combined with iStent inject W implantation (inject W-phaco) and microhook ab interno trabeculotomy (µLOT-phaco) using a fellow-eye design in patients with bilateral primary open-angle glaucoma (POAG). Methods: We retrospectively analyzed 44 eyes from 22 patients with primary open-angle glaucoma. In each patient, the eye with more advanced visual field loss underwent µLOT-phaco, whereas the fellow eye underwent inject W-phaco. Intraocular pressure (IOP), glaucoma medication use, anterior chamber flare (ACF), corneal endothelial cell density, complications, cumulative surgical success, and Humphrey Field Analyzer mean deviation (HFA MD) were evaluated over 36 months using statistical methods that accounted for the paired-eye design. Results: At 36 months, mean IOP was 13.0 ± 1.5 mmHg after µLOT-phaco and 13.4 ± 1.7 mmHg after inject W-phaco. Medication use decreased to 0.8 ± 1.1 in both groups. ACF returned to not significantly different from baseline earlier after inject W-phaco. Longitudinal HFA MD change did not differ significantly between procedures. Conclusions: Both procedures were associated with sustained reductions in IOP and medication use over 3 years; postoperative anterior chamber inflammation resolved earlier after inject W-phaco.

  • Open Access

    The Three-Year Outcomes of Microhook ab Interno Trabeculotomy Combined with Phacoemulsification in Japanese Patients with Cataract and Open-Angle Glaucoma

    by Kana Sase, Yasushi Kitaoka, Chihiro Tsukahara, Yasuhiro Toyoda, Ayaka Tsukamoto, Naoto Tokuda

    Background and Objectives: This study aimed to report the efficacy of microhook ab interno trabeculotomy with phacoemulsification three years after the operation. Materials and Methods: This retrospective observational study over 3 years included 16 glaucoma patients (27 eyes) who underwent microhook ab interno trabeculotomy with phacoemulsification at St. Marianna University Hospital from April 2020 to March 2021. Preoperative and postoperative best-corrected visual acuity (BCVA), intraocular pressure (IOP), antiglaucoma medication scores, and mean deviation (MD) slope were analyzed. Results: The preoperative mean IOP was 16.2 ± 4.4 mmHg, and this IOP decreased significantly to 12.6 ± 1.8, 13.0 ± 2.1, 12.0 ± 1.8, 12.4 ± 2.0, 12.6 ± 1.9 and 12.3 ± 1.3 mmHg at 6, 12, 18, 24, 30 and 36 months after the operation, respectively. The preoperative mean BCVA (LogMAR) was 0.1 ± 0.2 and this was improved significantly to 0.012 ± 0.20, 0.0078 ± 0.20, 0.0013 ± 0.16, −0.001 ± 0.14, 0.007 ± 0.17, and 0.010 ± 0.20 at 6, 12, 18, 24, 30 and 36 months after the operation. The preoperative antiglaucoma medication score was 3.11 ± 1.26, and this score decreased significantly to 0.22 ± 0.62, 0.44 ± 0.79, 0.48 ± 0.79, 0.63 ± 0.87, 0.63 ± 0.87 and 0.85 ± 0.93 at 6, 12, 18, 24, 30 and 36 months after the operation, respectively. The postoperative MD slope was significantly more positive than the preoperative slope (estimated difference, 0.330 dB/year; SE, 0.116; p = 0.0084). Conclusions: These findings suggest that microhook ab interno trabeculotomy with phacoemulsification can reduce IOP and medication burden and improved visual acuity through 3 years. Although there is potential beneficial effect, further study will be needed to prove its effect on visual field progression.

  • Risk factors for occurrence of reverse pupillary block after intraocular lens fixation surgery

    by Masaki Yuma, Tatsuya Jujo, Keiji Sato, Reio Sekine, Naoki Fujita, Naoto Uchiyama, Kota Kakehashi, Akiko Endo, Naoto Tokuda, Yasushi Kitaoka

    Purpose: To identify risk factors for reverse pupillary block (RPB) by retrospectively analyzing anterior segment optical coherence tomography (AS-OCT) images after intraocular lens (IOL) fixation surgery. Setting: Department of Ophthalmology, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan. Design: Retrospective observation study. Methods: 60 eyes that underwent scleral-sutured or intrascleral IOL fixation at our institution, from October 2019 to August 2023. Of these, 54 eyes did not develop RPB (RPB− group), whereas 6 eyes did (RPB+ group). Within 1 month postoperatively, AS-OCT was used to measure iris length, IOL–iris distance, anterior chamber depth (ACA), anterior chamber width, angle-to-angle distance, steep and flat meridian keratometry, and central corneal thickness. These parameters were compared between the 2 groups. The significant differences parameters were further analyzed using multivariate nominal logistic regression to calculate odds ratios for RPB development. Results: The RPB (+) group showed significantly better postoperative logMAR corrected distance visual acuity compared with the RPB (−) group ( P = .04). No significant differences were observed in intraocular pressure, axial length, or history of ocular or systemic conditions. AS-OCT analysis revealed that iris length was significantly greater in the RPB (+) group ( P = .01), while no significant differences were found in IOL–iris distance, ACA, or other parameters. Multivariate nominal logistic regression identified iris length as a significant risk factor for RPB, with an odds ratio of 32.9 ( P < .01). Conclusions: Longer iris length may be associated with an increased risk of RPB after intraocular lens fixation surgery.

  • Open Access

    Axonal protection by nicotinamide riboside with the SIRT1-AMPK pathway in TNF-induced optic nerve damage

    by Yasushi Kitaoka, Chihiro Tsukahara, Naoki Fujita, Ibuki Arizono, Mizuki Otsubo, Kana Sase

    Background Nicotinamide riboside (NR) is an NAD+ precursor and is reported to upregulate NAD+ levels in several tissues. We previously demonstrated that NR exhibited protection against axon loss induced by tumor necrosis factor (TNF) with upregulation of SIRT1 and enhancement of autophagy. We recently found that NR upregulated phosphorylated adenosine monophosphate-activated protein kinase (p-AMPK) protein in the optic nerve. The present study aimed to examine whether a SIRT1 inhibitor prevents axonal protection by NR and alters p-AMPK expression. Methods and results Rats were given intravitreal injection of a SIRT1 inhibitor prior to simultaneous injection of NR and TNF. The SIRT1 inhibitor alone or NR alone group was also made. SIRT1 and p-AMPK expression in optic nerve was investigated by immunoblot analysis. We examined the localization of SIRT1 and p-AMPK in the retina and optic nerve. Morphometric analysis showed axonal protection by NR in TNF-induced axon loss, and this protective effect was significantly prevented by the SIRT1 inhibitor. The SIRT1 inhibitor alone did not alter axon numbers significantly compared with the control group. The SIRT1 inhibitor significantly decreased p-AMPK levels in optic nerves in NR plus TNF-treated eyes. On the other hand, the SIRT1 inhibitor alone did not alter p-AMPK levels. Co-localization of SIRT1 and p-AMPK was observed in the retina and optic nerves in NR-treated eyes. Conclusions SIRT1 exists upstream of AMPK, and axonal protection of NR is associated with the SIRT1-AMPK pathway.

  • Open Access

    Clinical Outcomes of Full-Thickness Macular Holes with Epiretinal Proliferation Without Posterior Vitreous Detachment

    by Kota Kakehashi, Reio Sekine, Tatsuya Jujo, Naoto Uchiyama, Akiko Endo, Naoto Tokuda, Yasushi Kitaoka

    Background and Objective: To elucidate the clinical characteristics of full-thickness macular holes (FTMHs) with epiretinal proliferation (EP) without posterior vitreous detachment (PVD). Material and Methods: A retrospective and exploratory study reviewed clinical records of patients with FTMHs with EP without PVD (5 eyes: EP group) and FTMHs without EP without PVD (32 eyes: non-EP group). Swept-source OCT images were analyzed for macular structure. Statistical comparisons were made between clinical characteristics and surgical outcomes. Results: The EP group had two eyes with non-closure of macular holes (40%) (p = 0.01) and three eyes with ellipsoid zone defects (60%) (p = 0.01 compared with the non-EP group). Conclusions: Although limited by a small sample size, this pilot study suggests that the observed trends—such as a lower closure rate and more outer retinal disruption in the EP group—may indicate differences in pathogenesis and surgical outcomes compared to the non-EP group. However, these findings should be interpreted with caution due to statistical limitations. Further prospective studies with larger cohorts are needed to validate these preliminary findings and better understand the underlying pathogenesis.


  • Intravitreal injection of SARM1 siRNA in TNF-induced optic nerve degeneration

    by Yasushi Kitaoka, Chihiro Tsukahara, Naoki Fujita, Ibuki Arizono, Mizuki Otsubo, Kana Sase

    Purpose Intravitreal injections of some drugs such as anti-VEGF antibodies are available for certain human ocular diseases. Meanwhile, inhibition of SARM1 has been reported to exert neuroprotection in several neurodegenerative disease models. The aim of the current study is to investigate whether intravitreal injection of SARM1 siRNA can protect axons against TNF-induced optic nerve degeneration model. Methods Rats were received with intravitreal injection of PBS, TNF, TNF + SARM1 siRNA or SARM1 siRNA alone. Pre-injection of SARM1 siRNA + TNF and pre-injection of control siRNA + TNF groups were also made. Immunoblot analysis was carried out to evaluate SARM1 expression in the optic nerve. Morphometric analysis was carried out to evaluate the effects of SARM1 siRNA against axon loss induced by TNF. Immunohistochemical analysis was carried out to examine the localization of SARM1 in cross-sectioned optic nerves. Results Immunoblot analysis showed that intravitreal injection of SARM1 siRNA significantly decreased the SARM1 protein level in the optic nerve. Unexpectedly, axonal loss in the simultaneous intravitreal injection of SARM1 and TNF was almost the same as that in the TNF injection alone group. Pre-injection of SARM1 siRNA did not prevent axonal loss induced by TNF. There were no changes in SARM1 protein level in optic nerves 1 week after TNF injection compared with the PBS-injected group. Immunohistochemical analysis showed that the SARM1 immunoreactivity was colocalized with GFAP immunoreactivity in cross-sectioned optic nerves in both TNF and control groups. Conclusion These results suggest that intravitreal injection of SARM1 siRNA may not prevent axonal degeneration induced by TNF.

  • Open Access

    RETINAL MIGRATION AND SURGICAL OUTCOME AFTER HEMI-TEMPORAL INTERNAL LIMITING MEMBRANE PEELING VERSUS CONVENTIONAL PEELING FOR MACULAR HOLE

    by Tatsuya M.D. Jujo, Akira M.D. Shiono, Keiji M.D. Sato, Reio M.D. Sekine, Naoto M.D Uchiyama, Kota M.D Kakehashi, Akiko M.D Endo, Akira M.D. Arakawa, Youichiro M.D Shinkai, Yasushi M.D. Kitaoka

    Purpose: To investigate the anatomical changes and surgical outcomes of hemi-temporal internal limiting membrane (ILM) peeling and conventional ILM peeling for idiopathic macular hole (MH). Methods: This randomized controlled trial was conducted at 3 centers and included 50 participants with MHs of µm in minimum diameter for a duration of P = 0.009). Retinal migration to the optic disk on the nasal side was significantly shorter in the Hemi group at 1, 3, and 6 months postoperatively than in the 360° group. There was no significant difference between the two groups in retinal migration to the optic disk on the temporal side. Conclusion: Nasal retinal migration in patients who underwent the hemi-temporal ILM peeling method was significantly less than in those who underwent the 360° ILM peeling method. However, less nasal retinal migration did not contribute to the MH closure rate.


  • Open Access

    Axonal Protection by Oral Nicotinamide Riboside Treatment with Upregulated AMPK Phosphorylation in a Rat Glaucomatous Degeneration Model

    by Ibuki Arizono, Naoki Fujita, Chihiro Tsukahara, Kana Sase, Reio Sekine, Tatsuya Jujo, Mizuki Otsubo, Naoto Tokuda, Yasushi Kitaoka

    Nicotinamide riboside (NR), a precursor of nicotinamide adenine dinucleotide (NAD+), has been studied to support human health against metabolic stress, cardiovascular disease, and neurodegenerative disease. In the present study, we investigated the effects of oral NR on axonal damage in a rat ocular hypertension model. Intraocular pressure (IOP) elevation was induced by laser irradiation and then the rats received oral NR of 1000 mg/kg/day daily. IOP elevation was seen 7, 14, and 21 days after laser irradiation compared with the controls. We confirmed that oral NR administration significantly increased NAD+ levels in the retina. After 3-week oral administration of NR, morphometric analysis of optic nerve cross-sections showed that the number of axons was protected compared with that in the untreated ocular hypertension group. Oral NR administration significantly prevented retinal ganglion cell (RGC) fiber loss in retinal flat mounts, as shown by neurofilament immunostaining. Immunoblotting samples from the optic nerves showed that oral NR administration augmented the phosphorylated adenosine monophosphate-activated protein kinase (p-AMPK) level in rats with and without ocular hypertension induction. Immunohistochemical analysis showed that some p-AMPK-immunopositive fibers were colocalized with neurofilament immunoreactivity in the control group, and oral NR administration enhanced p-AMPK immunopositivity. Our findings suggest that oral NR administration protects against glaucomatous RGC axonal degeneration with the possible upregulation of p-AMPK.


  • Open Access

    Axonal Protection by Netarsudil, a ROCK Inhibitor, Is Linked to an AMPK-Autophagy Pathway in TNF-Induced Optic Nerve Degeneration

    by Yasushi Kitaoka, Kana Sase, Chihiro Tsukahara, Naoki Fujita, Ibuki Arizono, Jiro Kogo, Naoto Tokuda, Hitoshi Takagi

    Purpose: Netarsudil, a Rho kinase inhibitor with norepinephrine transport inhibitory effect, lowers intraocular pressure, however, its effect on axon damage remains to be elucidated. The aim of the current study was to investigate the effect of netarsudil on TNF-induced axon loss and to examine whether it affects phosphorylated-AMP-activated kinase (p-AMPK) and autophagy in the optic nerve. Methods: Intravitreal administration of TNF or TNF with netarsudil was carried out on rats and quantification of axon number was determined. Electron microscopy determined autophagosome numbers. Localization of p-AMPK expression was examined by immunohistochemistry. The changes in p62, LC3-II, and p-AMPK levels were estimated in the optic nerve by immunoblot analysis. The effect of an AMPK activator A769662 or an AMPK inhibitor dorsomorphin on axon number was evaluated. Results: Morphometric analysis revealed apparent protection by netarsudil against TNF-induced axon degeneration. Netarsudil increased autophagosome numbers inside axons. Netarsudil treatment significantly upregulated optic nerve LC3-II levels in both the TNF-treated eyes and the control eyes. Increased p62 protein level induced by TNF was significantly ameliorated by netarsudil. The netarsudil administration alone lessened p62 levels. Netarsudil significantly upregulated the optic nerve p-AMPK levels. A769662 exhibited obvious axonal protection against TNF-induced damage. A769662 treatment upregulated LC3-II levels and the increment of p62 level induced by TNF was significantly ameliorated by A769662. Immunohistochemical analysis revealed that p-AMPK is present in axons. Netarsudil-mediated axonal protection was significantly suppressed by dorsomorphin administration. Conclusions: Netarsudil upregulated p-AMPK and autophagy. Netarsudil-mediated axonal protection may be associated with upregulated p-AMPK.